Business
Somero: A Near-Monopoly Toll on Flat Concrete Floors
Somero makes one thing exceptionally well: laser-guided machines that lay large concrete floors flatter, faster, and with fewer workers. It pioneered the Laser Screed in 1986, owns an estimated 80%-plus share of a niche it effectively created, and earns gross margins above 50% and through-cycle operating margins near 30% — economics no listed "peer" in construction machinery comes close to. The catch is the other side of the same coin: a single product family, sold into the most cyclical corner of construction (private non-residential — warehouses, distribution centres, factories), with revenue that just fell 33% from its 2022 peak and net income down 71%. This is a high-quality, fortress-balance-sheet compounder trading through a cyclical trough. The investment question is not "is it a good business" — it plainly is — but "what is normalized earning power worth, and is the cycle turning?"
Verdict: A genuine niche near-monopoly with structurally superior margins, ~17% trough ROIC, zero debt and net cash worth ~28% of the market value — but deeply cyclical and structurally low-growth. Value it on normalized through-cycle free cash flow and shareholder yield, not trough or peak earnings.
FY2025 Revenue ($M)
▼ -19% YoY
Gross Margin
Adj. EBITDA ($M)
Net Cash ($M)
Free Cash Flow Yield
Dividend Yield
Source: FY2025 Annual Report (Financial Review, Chairman and CEO Statement); free cash flow and dividend yields derived from reported financials at the current ~$119M market value.
The industry primer already covers the laser-screed category and its cycle; this page underwrites Somero specifically — how it earns money, how durable the moat is, how violent the cycle is, and what the business is worth.
The Economic Engine: A Premium Razor With a Resilient Aftermarket
Somero sells expensive, productivity-enhancing capital equipment to concrete contractors, then earns a steady annuity servicing the installed base. The "razor" is the machine — Boomed screeds (the large self-propelled units) plus Ride-on screeds are roughly 57% of revenue. The "blades" are parts, service, training, 3D Profiler systems and remanufactured trade-ins — recurring, higher-stickiness revenue that holds up far better in downturns.
Source: FY2025 Annual Report, Financial Review revenue table (footnote 14).
Why the economics are so good comes down to value-based pricing on a tiny slice of the customer's cost. A Laser Screed lets a contractor place a floor with fewer labourers, faster, and flatter — winning "Golden Trowel" flatness awards that win the contractor more work. The machine is a small line-item against a multi-million-dollar pour but a large lever on the contractor's labour bill and bid competitiveness. That lets Somero hold gross margins of 52%–58% while its customers operate on thin, cost-plus margins. The aftermarket then compounds the advantage: every machine sold in 90-plus countries seeds decades of parts, service and training revenue at high margin.
The second structural feature is a variable cost base. Somero assembles rather than heavily manufactures, carries almost no debt, and flexes headcount and incentive comp with volume. That is why — even with revenue down 19% in 2025 — it still produced a 20% adjusted EBITDA margin and grew operating cash flow. The model is built to stay profitable through the trough, not just the peak.
The tell: In FY2025 — a cyclical trough — Somero's 15.7% operating margin and 52% gross margin still beat every listed construction-machinery peer at mid-cycle. Through the cycle (FY2016–2023) operating margins averaged ~30%.
The Moat: Real, Layered, and Mechanism-Backed — but Not Impregnable
Somero's market leadership is not a marketing claim; it is visible in the margin structure and corroborated by independent research that pegs its share of the laser-screed niche above 80%. The moat is layered, and each layer has a concrete mechanism:
Protected technology. 140-plus patents/applications versus roughly half a dozen at its closest rival. Somero litigates infringement aggressively, which raises the cost and risk of copying its laser-guidance and boom designs.
Switching and competence costs. The value of the machine is realised only with trained operators. Somero's Concrete College/Institute, VR training, 24/7 multilingual support and overnight parts delivery embed it in the contractor's workflow — a service moat a low-cost clone cannot replicate.
Installed base + dealer network. Four decades of machines in 90-plus countries create an aftermarket annuity and reference base (Amazon, Walmart, Prologis, IKEA floors) that compounds brand specification advantage.
Niche-size deterrence. The total market is small enough that a large entrant (Caterpillar, Komatsu) gains nothing meaningful by entering, yet specialised enough that scale, IP and service create a durable barrier for small ones.
Where an honest analyst must flag risk: the moat is thinner at the low end and abroad. The clearest threats are private US rival Ligchine (founded 2007, boomed/ride-on laser screeds), and low-cost Chinese manufacturers undercutting in the $20k–$50k bracket, particularly in Europe where 2025 revenue fell 39% and management openly cites "intense" competition. Somero's response — the new, value-priced Hammerhead and a Belgium service centre/institute — is a defensive move down-market that could pressure mix and margin even if it protects share. The moat protects the core; it does not guarantee growth.
The Cycle Is the Story: Violent Operating Leverage
Somero is a pick-and-shovel bet on private non-residential construction starts, and that demand is feast-or-famine. Revenue nearly doubled into the 2021–22 post-COVID boom, then fell three straight years as tariffs, interest rates, labour shortages and policy uncertainty froze large-project decisions. Because the cost base is semi-fixed in the short run, profit swings far harder than revenue.
Source: reported income statements, FY2013–FY2025.
The asymmetry is the whole point. From the 2022 revenue peak to 2025, revenue fell 33% but net income fell 71% — that is roughly 2x downside operating leverage. The same gearing works in reverse on the way up. So the headline FY2025 P/E of ~16x is misleading: it is a trough multiple on trough earnings, which always looks expensive at the bottom and cheap at the top.
Margin resilience, however, is the quality signal hiding inside the cyclicality — operating margin has never gone negative and bottomed at a still-healthy ~16% in the worst year of the past decade.
Source: derived from reported income statements, FY2013–FY2025.
Demand is also geographically concentrated: North America is 77% of revenue, so the US private non-residential cycle is the single most important variable for the stock. Europe, Australia and Rest-of-World are the diversification thesis — and the competitive battleground — but together still only ~23%.
Source: FY2025 Annual Report, Global Market Overview and Financial Review (North America 77%, Europe 10%, Australia 6%, Rest of World 7%).
Quality Check: Somero vs the "Peers"
There is no listed pure-play competitor — the truest rivals (Ligchine, Allen Engineering, Multiquip) are private. The listed comparison set is therefore adjacent construction-machinery names, useful for one purpose: showing how unusual Somero's economics are. Even in its worst year, Somero out-earns every one of them, and its mid-cycle profitability is in a different league entirely.
Source: FY2025 reported financials per company; SOM FY2021 peak shown for through-cycle context. Valuation multiples per latest reported ratios and market values. Peer set is adjacent (no listed pure-play laser-screed competitor exists).
The picture is stark when margin is plotted against valuation: Somero sits far to the right (high profitability) while trading at a mid-pack EV/EBITDA — and that EV/EBITDA is calculated on trough EBITDA.
Source: FY2025 reported financials and latest market values. Somero shown at its trough operating margin; on mid-cycle margins (~30%) it would sit far further right.
The economic twin in this set is Gencor — similar size, net cash, deep cyclicality — and notably it too earns more in net than operating margin because, like Somero, idle cash throws off interest income. But even Gencor lacks Somero's pricing power and aftermarket annuity.
Cash Machine and Fortress Balance Sheet
The business converts profit to cash almost completely and needs very little capital to run. Capex is routinely under 1% of revenue (just $0.8M in 2025); the asset base is inventory and a modest assembly footprint, not heavy plant. Free cash flow has been positive every year shown and actually rose in 2025 despite lower profit, helped by working-capital release and customer deposits.
Source: reported cash flow statements, FY2018–FY2025.
The balance sheet is a genuine differentiator and a downside cushion. Somero ended 2025 debt-free with $33.2M net cash — about 28% of its market value — plus an undrawn $25M credit line. Return on invested capital was ~17% even at the trough (and ~34% through the cycle per external estimates), held down at the equity level only because of the large idle cash buffer (ROE 12.3%). This is a business that earns high returns on the small amount of capital it actually employs, and parks the rest.
Net Cash ($M)
FY25 Free Cash Flow ($M)
ROIC (trough)
Capex / Sales
Source: FY2025 reported financials; ROIC and capex intensity derived from reported figures.
Capital Allocation: Disciplined Return of Cash
With low capital needs and high cash conversion, the defining capital-allocation question is what to do with the surplus — and Somero's answer has been return almost all of it. Over FY2013–FY2025 the company paid out roughly $164M in dividends and $27M in buybacks — about $190M, well above its entire current market value — while never taking on debt. The policy is now formalised: an ordinary dividend at 50% of adjusted net income (a payout that flexes with the cycle, protecting the balance sheet), buybacks sized to offset equity-award dilution, and opportunistic repurchases. The current ordinary dividend yield is ~5.7% and total shareholder yield ~8%.
The one change worth watching: management has, for the first time, built a formal M&A framework (ROIC above cost of capital, FCF-accretive, up to 2.0x net-debt-to-EBITDA reserved for deals) and hired advisers. After decades as a disciplined single-product cash-returner, Somero is signalling it may deploy the balance sheet to buy growth. That is a sensible response to a structurally low-growth core — but it introduces execution and capital-allocation risk that has not previously been part of this story.
How To Value It
Somero is best underwritten as a high-quality cyclical cash compounder, valued on normalized through-cycle free cash flow plus shareholder yield — explicitly not on spot P/E, which mechanically misleads at cyclical extremes.
Source: trough and peak are reported net income; mid-cycle is the FY2019–FY2024 average of reported net income.
Against a market value of roughly $119M (EV ~$96M after net cash), the lenses tell a consistent story:
On trough earnings (FY2025): ~16x P/E, ~7.9x EV/EBITDA, ~10.6% FCF yield. Optically full on the multiple, but generous on cash.
On mid-cycle earnings (~$25M net income, ~$25–30M EBITDA): roughly 5x normalized P/E and ~3.5x EV/EBITDA — strikingly cheap for an 80%-share, net-cash, 30%-margin niche leader.
On cash return: a ~5.7% dividend that is cycle-protected by the 50%-of-adjusted-earnings policy, plus buybacks — ~8% total shareholder yield while you wait.
The bull case is that you are buying a structurally superior business at a cyclical low, with the balance sheet and dividend paying you to be patient, and US private non-residential drivers (onshoring, data centres, logistics) eventually reaccelerating starts. The bear case is equally clear and must be respected: the core market is mature and structurally low-growth (mid-single-digit at best), North America concentration is high, competition is intensifying at the low end and in Europe, and the new M&A ambition could erode the very discipline that made the balance sheet a fortress. The 2026 guidance — revenue, profit and cash "broadly comparable to 2025" — says the trough may be a plateau, not yet a recovery.
Bottom line: A wonderful little business at a cyclical low, priced fairly on trough earnings and cheaply on normalized earnings — but the upside is gated by a low structural growth ceiling and US-cycle timing. Underwrite the normalized cash flows and the shareholder yield; do not pay for, or panic at, the cycle.